Stepwise two-stage sample size adaptation

Statistics in Medicine

Volumn 34, Issue 1, 2015, Pages 27-38

  Wan, Hong ^a   Ellenberg, Susan S ^b   Anderson, Keaven M ^c  

^a SHIRE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adaptive design; Optimal design; Sample size reestimation

Indexed keywords

HUMAN; METHODOLOGY; PROBABILITY; SAMPLE SIZE; STATISTICAL BIAS; STATISTICAL MODEL;

BIAS (EPIDEMIOLOGY); HUMANS; MODELS, STATISTICAL; PROBABILITY; RESEARCH DESIGN; SAMPLE SIZE;

EID: 84914816507     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.6311     Document Type: Article

References (18)

1. Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics 1995; 51: 1315-1324.
2. Liu Q, Chi GYH. On sample size and inference for two-stage adaptive designs. Biometrics 2001; 57: 172-177.
3. Anderson KM, Liu Q . Optimal adaptive vs. optimal group sequential designs, 2004. (Available from: http://www.bassconference.org/about/past/2004) [Accessed on 27 July 2014].
4. Cui L, Hung HM, Wang SJ. Modification of sample size in group sequential clinical trials. Biometrics 1999; 55: 853-857.
5. Müller HH, Schäffer H. Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches. Biometrics 2001; 57: 886-891.
6. Posch M, Bauer P, Brannath W. Issues in designing flexible trials. Statistics in Medicine 2003; 22: 953-965.
7. Lokhnygina Y, Tsiatis AA. Optimal two-stage group-sequential designs. Journal of Statistical Planning and Inference 2008; 138: 489-499.
8. Schmitz N. Optimal Sequentially Planned Decision Procedures. Springer: New York, 1993.
9. Barber S, Jennison C. Optimal asymmetric one-sided group sequential tests. Biometrika 2002; 89: 49-60.
10. Gao P, Ware JH, Mehta C. Sample size re-estimation for adaptive sequential design in clinical trials. J Biopharm Stat 2008; 18: 1184-1196.
11. Mehta CR, Pocock SJ. Adaptive increase in sample size when interim results are promising: a practical guide with examples. Statistics in Medicine 2010; 30: 3267-3284.
12. Ellenberg SS, Golub H, Mehta C. Preface to proceedings of workshop adaptive clinical trial designs: ready for prime time?Statistics in Medicine 2006; 25: 3229-3230.
13. Anderson KM. Optimal spending functions for asymmetric group sequential designs. Biometricl Journal 2007; 49: 337-345.
14. Jennison C, Turnbull BW. Group Sequential Methods with Applications to Clinical Trials. Chapman and Hall/CRC: Boca Raton, FL, 2000.
15. Chen YHJ, Demets DL, Lan KKG. Increasing the sample size when the unblinded interim result is promising. Statistics in Medicine 2004; 23: 1023-1038.
16. Jennison C, Turnbull BW. Mid-course sample size modification in clinical trials based on the observed treatment effect. Statistics in Medicine 2003; 22: 971-993.
17. Levin GP, Emerson SC, Emerson SS. Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation. Statistics in Medicine 2013; 32: 1259-1275.
18. Chuang-Stein C, Anderson KM, Gallo P, Colllins S. Sample size reestimation: a review and recommendations. Drug Information Journal: 2006; 40 475-484.